Table 2 Radiological characteristics of lungs before drug therapy
From: Lung nodules and IgG4 related disease: a single-center based experience
Patients with indicated lung nodules | n (%) | ||
|---|---|---|---|
Size | |||
Small nodule only | Â | single | 7(12.0) |
multiple | 38(78.0) | ||
Large nodule only | 2(4.0) | ||
Both small and large nodule | 3(6.0) | ||
Distribution | |||
 Laterality | |||
 Unilateral | 16(32.0) | ||
 Bilateral | 34(68.0) | ||
Lobe | |||
 Upper lobe | 6(12.0) | ||
 Middle or lower lobe | 12(24.0) | ||
 Random | 32(64.0) | ||
Type | |||
 Ground-glass nodule only | 1(2.0) | ||
 Solid nodule only | 46(92.0) | ||
 Both ground-glass and solid nodule | 3(6.0) | ||
Margin | |||
 Irregular or untidy | 6(12.0) | ||
 Regular | 44(88.0) | ||
Second associated features | |||
 Lobulation | 3(6.0) | ||
 Spiculation | 3(6.0) | ||
 Pleural retraction | 2(4.0) | ||
 Calcification | 1(2.0) | ||
Changes of nodules after treatments(n = 16) | |||
 Smaller or disappear | 10(20.0) | ||
 No difference | 6(12.0) | ||
Other radiological features | |||
 Ground-glass opacity | 21(42.0) | ||
 Thickening of pleura | 9(18.0) | ||
 Thickening of interlobular septa | 4(8.0) | ||
 Thickening of bronchial wall | 3(6.0) | ||
 Pleura effusion | 4(8.0) | ||
 Mass | 3(6.0) | ||
 Consolidation | 1(2.0) | ||
 Interstitial changes | 5(6.0) | ||
 Mediastinal and hilar lymphadenopathy | 32(64.0) | ||